Literature DB >> 17604850

Sequential polymicrobial infections lead to CNS inflammatory disease: possible involvement of bystander activation in heterologous immunity.

Ikuo Tsunoda1, Jane E Libbey, Robert S Fujinami.   

Abstract

VV(PLP) is a recombinant vaccinia virus (VV) encoding myelin proteolipid protein (PLP) that has been used to investigate molecular mimicry and autoimmunity. Since virus infections can cause bystander activation, mice were first infected with VV(PLP), and later challenged with wild-type VV, lymphocytic choriomeningitis virus (LCMV), or murine cytomegalovirus (MCMV). Among the VV(PLP)-primed mice, only MCMV challenge induced significant Ki-67(+), CD3(+)T cell infiltration into the central nervous system (CNS) with a mild PLP antibody response. While MCMV alone caused no CNS disease, control VV-infected mice followed with MCMV developed mild CNS inflammation. Thus, heterologous virus infections can induce CNS pathology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604850      PMCID: PMC1987327          DOI: 10.1016/j.jneuroim.2007.05.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  63 in total

Review 1.  The case for rhinoviruses in the pathogenesis of multiple sclerosis.

Authors:  John D Kriesel; William A Sibley
Journal:  Mult Scler       Date:  2005-02       Impact factor: 6.312

2.  Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B.

Authors:  I Tsunoda; Y Wada; J E Libbey; T S Cannon; F G Whitby; R S Fujinami
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Neurovirulence of vaccinia viruses for mice.

Authors:  M Soekawa; C Morita; R Moriguchi; M Nakamura
Journal:  Zentralbl Bakteriol Orig A       Date:  1974-06

4.  Viruses can silently prime for and trigger central nervous system autoimmune disease.

Authors:  D J Theil; I Tsunoda; F Rodriguez; J L Whitton; R S Fujinami
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

5.  Communicating hydrocephalus in newborn hamsters and cats following vaccinia virus infection.

Authors:  L E Davis
Journal:  J Neurosurg       Date:  1981-06       Impact factor: 5.115

Review 6.  Pediatric multiple sclerosis.

Authors:  Brenda L Banwell
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

Review 7.  No one is naive: the significance of heterologous T-cell immunity.

Authors:  Raymond M Welsh; Liisa K Selin
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

8.  Murine cytomegalovirus infection: hematological, morphological, and functional study of lymphoid cells.

Authors:  K S Cheung; J K Li; J M Falletta; J L Wagner; D J Lang
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

9.  IL-12 unmasks latent autoimmune disease in resistant mice.

Authors:  B M Segal; E M Shevach
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

10.  Cellular and humoral immunity against vaccinia virus infection of mice.

Authors:  Rong Xu; Aaron J Johnson; Denny Liggitt; Michael J Bevan
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  11 in total

1.  Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.

Authors:  Nicholas E Martinez; Fumitaka Sato; Eiichiro Kawai; Seiichi Omura; Satoru Takahashi; Keigyou Yoh; Ikuo Tsunoda
Journal:  Brain Behav Immun       Date:  2014-07-18       Impact factor: 7.217

Review 2.  Bystander T Cells: A Balancing Act of Friends and Foes.

Authors:  Sarah K Whiteside; Jeremy P Snook; Matthew A Williams; Janis J Weis
Journal:  Trends Immunol       Date:  2018-11-06       Impact factor: 16.687

Review 3.  Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Vaccine       Date:  2010-09-16       Impact factor: 3.641

Review 4.  Studies in the modulation of experimental autoimmune encephalomyelitis.

Authors:  Jane E Libbey; Ikuo Tsunoda; Robert S Fujinami
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-17       Impact factor: 4.147

5.  Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection.

Authors:  Ikuo Tsunoda
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

Review 6.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

Review 7.  Molecular mimicry as a mechanism of autoimmune disease.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667

8.  CMV infection attenuates the disease course in a murine model of multiple sclerosis.

Authors:  Istvan Pirko; Rhonda Cardin; Yi Chen; Anne K Lohrey; Diana M Lindquist; R Scott Dunn; Robert Zivadinov; Aaron J Johnson
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

9.  Possible role of interleukin-17 in a prime/challenge model of multiple sclerosis.

Authors:  Jane E Libbey; Ikuo Tsunoda; Robert S Fujinami
Journal:  J Neurovirol       Date:  2012-09-19       Impact factor: 3.739

Review 10.  Potential triggers of MS.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Results Probl Cell Differ       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.